Dr Michelle Miller, BSc, MSc, PhD GCertAppFin (Finsia)
Chief Executive Officer and Managing Director
Dr Miller has worked for over 25 years in the bioscience industry, with extensive experience in commercial drug development. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes several years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund.
Dr Miller was appointed as Managing Director on 21 June 2002.
Dr Stephen Becker, MD
Chief Medical Officer
Stephen Becker has had an extensive career as a pharmaceutical development executive in both the public and private sector organizations. He has worked extensively in the HIV and antiviral therapeutic arenas, as well at the interface of viral and cancer immunology.
Dr Becker worked for more than 6 years at the Bill & Melinda Gates foundation where he led HIV treatment, prevention and cure efforts. This included early stage development of long-acting antiretrovirals, and broadly neutralizing antibodies. He coordinated foundation-supported efforts with the NIH, biopharma, WHO and global regulatory agencies.
Dr Becker’s career in HIV began in the early 1980s while a faculty member at UCSF where he led a large HIV clinical practice, and clinical research program. His areas of research included pharmacology and pharmacogenetics, early stage drug development, and health service outcomes research.
Dr Becker was a Robert Wood Johnson Clinical Scholar at the joint UCSF-Stanford program, prior to joining the USCF faculty. He completed his internal medicine training at Cook County Hospital. He is a graduate of the SUNY/Buffalo School of Medicine, and the University of Pennsylvania.
Currently Dr Becker works as a medical and scientific consultant to biotech and global health philanthropic foundations.
Mr Peter J. Nightingale
Mr Nightingale graduated with a Bachelor of Economics degree from the University of Sydney and is a member of the Chartered Accountants Australia and New Zealand. He has worked as a chartered accountant in both Australia and the USA.
As a director or company secretary Mr Nightingale has, for more than 35 years, been responsible for the financial control, administration, secretarial and in-house legal functions of a number of private and public listed companies in Australia and the USA including Bolnisi Gold N.L. and Nickel Industries Limited.
Mr Nightingale is currently a director of ASX listed companies Alpha HPA Limited and Prospech Limited and unlisted public company Fulcrum Lithium Ltd.
Mr Nightingale has been Company Secretary since 23 February 1999.